{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:29:05Z","timestamp":1777328945373,"version":"3.51.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1093\/carcin\/bgt019","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T01:39:15Z","timestamp":1359077955000},"page":"1115-1124","source":"Crossref","is-referenced-by-count":28,"title":["Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2"],"prefix":"10.1093","volume":"34","author":[{"given":"Daria","family":"Witt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Burfeind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"von Hardenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Salinas-Riester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bremmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schweyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Thelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Neesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Kaulfu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"key\n\t\t\t\t20170520234011_CIT0001","article-title":"Cancer facts and figures","author":"American Society of Cancer","year":"2010"},{"key":"key\n\t\t\t\t20170520234011_CIT0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA. Cancer J. Clin"},{"key":"key\n\t\t\t\t20170520234011_CIT0003","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/1535-7163.MCT-08-0860","article-title":"Epigenetics in cancer: targeting chromatin modifications","volume":"8","author":"Ellis","year":"2009","journal-title":"Mol. Cancer Ther"},{"key":"key\n\t\t\t\t20170520234011_CIT0004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.molmed.2007.07.003","article-title":"Chromatin remodeling and cancer, Part I: covalent histone modifications","volume":"13","author":"Wang","year":"2007","journal-title":"Trends Mol. Med"},{"key":"key\n\t\t\t\t20170520234011_CIT0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0006","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170520234011_CIT0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18632\/oncotarget.106","article-title":"Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome","volume":"1","author":"Raffoux","year":"2010","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170520234011_CIT0008","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1371\/journal.pone.0000098","article-title":"A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer","volume":"1","author":"Arce","year":"2006","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170520234011_CIT0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-4598-4-22","article-title":"Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study","volume":"4","author":"Chavez-Blanco","year":"2005","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20170520234011_CIT0011","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1128\/MCB.00605-06","article-title":"Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer","volume":"26","author":"Annicotte","year":"2006","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20170520234011_CIT0012","first-page":"1293","article-title":"Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells","volume":"32","author":"Iacopino","year":"2008","journal-title":"Int. J. Oncol"},{"key":"key\n\t\t\t\t20170520234011_CIT0013","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pros.20587","article-title":"Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo","volume":"67","author":"Shabbeer","year":"2007","journal-title":"Prostate"},{"key":"key\n\t\t\t\t20170520234011_CIT0014","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/1535-7163.MCT-07-0197","article-title":"The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment","volume":"6","author":"Stettner","year":"2007","journal-title":"Mol. Cancer Ther"},{"key":"key\n\t\t\t\t20170520234011_CIT0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10585-011-9386-8","article-title":"Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells","volume":"28","author":"Wedel","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"key\n\t\t\t\t20170520234011_CIT0016","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","article-title":"Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo","volume":"66","author":"Xia","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170520234011_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol"},{"key":"key\n\t\t\t\t20170520234011_CIT0018","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"key\n\t\t\t\t20170520234011_CIT0019","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/blood.V85.10.2870.bloodjournal85102870","article-title":"Overexpression of cyclin D2 in chronic B-cell malignancies","volume":"85","author":"Delmer","year":"1995","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520234011_CIT0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9440(10)64763-3","article-title":"Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases","volume":"156","author":"Takano","year":"2000","journal-title":"Am. J. Pathol"},{"key":"key\n\t\t\t\t20170520234011_CIT0021","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1349-7006.2011.02046.x","article-title":"Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"102","author":"Igawa","year":"2011","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t20170520234011_CIT0022","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00109-006-0099-4","article-title":"Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer","volume":"84","author":"Henrique","year":"2006","journal-title":"J. Mol. Med"},{"key":"key\n\t\t\t\t20170520234011_CIT0023","first-page":"4730","article-title":"Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation","volume":"9","author":"Padar","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20170520234011_CIT0024","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2009.06.146","article-title":"Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells","volume":"387","author":"Kobayashi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20170520234011_CIT0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lungcan.2012.03.027","article-title":"Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer","volume":"77","author":"Ko","year":"2012","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0026","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0027","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1038\/onc.2009.254","article-title":"Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression","volume":"28","author":"Kaulfu\u00df","year":"2009","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520234011_CIT0028","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/1535-7163.MCT-11-0422","article-title":"Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation","volume":"10","author":"Uhmann","year":"2011","journal-title":"Mol. Cancer Ther"},{"key":"key\n\t\t\t\t20170520234011_CIT0029","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/me.2006-0546","article-title":"Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells","volume":"22","author":"Kaulfuss","year":"2008","journal-title":"Mol. Endocrinol"},{"key":"key\n\t\t\t\t20170520234011_CIT0030","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M109.057836","article-title":"Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein","volume":"285","author":"Venkataramani","year":"2010","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20170520234011_CIT0031","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/molehr\/gaq060","article-title":"Pluripotent embryonic stem cells and multipotent adult germline stem cells reveal similar transcriptomes including pluripotency-related genes","volume":"16","author":"Meyer","year":"2010","journal-title":"Mol. Hum. Reprod"},{"key":"key\n\t\t\t\t20170520234011_CIT0032","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","article-title":"Prostate cancer in a transgenic mouse","volume":"92","author":"Greenberg","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"key\n\t\t\t\t20170520234011_CIT0033","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.humpath.2012.01.007","article-title":"Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases","volume":"43","author":"Toubaji","year":"2012","journal-title":"Hum. Pathol"},{"key":"key\n\t\t\t\t20170520234011_CIT0034","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/jcp.2004.016436","article-title":"DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer","volume":"57","author":"Padmanabhan","year":"2004","journal-title":"J. Clin. Pathol"},{"key":"key\n\t\t\t\t20170520234011_CIT0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/jpet.106.106658","article-title":"Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells","volume":"319","author":"Chen","year":"2006","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20170520234011_CIT0036","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat. Rev"},{"key":"key\n\t\t\t\t20170520234011_CIT0037","first-page":"407","article-title":"Serum ceruloplasmin as a marker in prostate cancer","volume":"59","author":"Fotiou","year":"2007","journal-title":"Minerva Urol. Nefrol"},{"key":"key\n\t\t\t\t20170520234011_CIT0038","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.bjc.6602709","article-title":"Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas","volume":"93","author":"Mermelshtein","year":"2005","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0039","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<194::AID-PATH426>3.0.CO;2-P","article-title":"Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis","volume":"189","author":"Takano","year":"1999","journal-title":"J. Pathol"},{"key":"key\n\t\t\t\t20170520234011_CIT0040","first-page":"2782","article-title":"Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation","volume":"61","author":"Evron","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170520234011_CIT0041","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.11393","article-title":"Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers","volume":"107","author":"Virmani","year":"2003","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0042","first-page":"1157","article-title":"Cyclin D2 expression in familial and sporadic breast cancer","volume":"9","author":"Fischer","year":"2002","journal-title":"Oncol. Rep"},{"key":"key\n\t\t\t\t20170520234011_CIT0043","first-page":"1446","article-title":"Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues","volume":"9","author":"Matsubayashi","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20170520234011_CIT0044","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.bjc.6600940","article-title":"Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer","volume":"88","author":"Yu","year":"2003","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170520234011_CIT0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0b013e32834a7e6f","article-title":"Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer","volume":"21","author":"Stettner","year":"2012","journal-title":"Eur. J. Cancer Prev"},{"key":"key\n\t\t\t\t20170520234011_CIT0046","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/MCB.18.6.3163","article-title":"Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells","volume":"18","author":"Meyyappan","year":"1998","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20170520234011_CIT0047","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4161\/cbt.11.10.15177","article-title":"Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort","volume":"11","author":"Swift-Scanlan","year":"2011","journal-title":"Cancer Biol. Ther"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/34\/5\/1115\/17293243\/bgt019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T05:29:38Z","timestamp":1595309378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgt019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,1,24]]},"published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgt019","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}